Eng
 
 
 
 

Medicine & Pharmaceutics

Pharmaceutics is traditionally one of the main industry sectors in the economy of Ukraine. National medicine market is expending very rapidly. Each year Ukrainian and foreign pharmaceutical companies launch dozens of new products. Private medical practice is on the rise as well. For the last few years Ukrainian and foreign private investors established a number of clinics, diagnostic centers and laboratories. INYURPOLIS tracks the latest trends in the field and provides its clients with comprehensive support in starting and/or operating medical and pharmaceutical businesses. For many years we permanently act as a legal counsel to the National Pharmaceutical University (Kharkiv) - one of the leading educational and research pharmaceutical institutions of Ukraine. Among our clients are: Children’s Medical Center “RADUGA”, Alpha Medical Group (one of the major players on the market of laboratory diagnostics in Central and Eastern Europe), JANSSEN-CILAG (our experts developed a strategy to protect the client’s original drug against a generic drug).


We offer our clients the following services:

  • Advising on establishment and restructuring of medical and/or pharmaceutical businesses;
  • Preparation of opinions on different issues of governmental regulation of medical and pharmaceutical business in Ukraine;
  • Structuring of and support in transactions aimed at acquisition of real property for location of medical and pharmaceutical institutions; perfection of title to such real estate;
  • Advising on purchase of medical and pharmaceutical equipment, including relevant import and customs regulations;
  • Standardization and certification of medical equipment, registration of equipment with the Ministry of Health of Ukraine;
  • Obtaining licenses and approvals required to conduct medical or pharmaceutical business in Ukraine;
  • Registration of drugs with the State Pharmacological Center of the Ministry of Health of Ukraine, registration of rights to drugs as intellectual property objects;
  • Development of strategies to protect rights to drugs, including protection against generics;
  • Representation in courts in cases on protection of rights to drugs.